Haematological Toxicities Following Treatment of Childhood Hepatoblastoma with Intensive Multiagent Chemotherapy
Haematology Journal of Bangladesh · 2020
DOI: 10.37545/haematoljbd20172 ↗Kurz gefasst
Fachartikel in der Zeitschrift Haematology Journal of Bangladesh, 2020. Verfasst von Farida Yasmin und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Hepatoblastoma is a rare malignant liver tumour that occurs almost exclusively in childhood. Although surgical resection is the foundation of curative therapy, with the use of effective neoadjuvant and adjuvant chemotherapy the 5 years overall survival of patient with hepatoblastoma had recently reached up to 80% to 90 %. But the frequency and severity of haematological toxicity is one of the major concerns of intensive chemotherapy.
Objective
To evaluate the frequency and severity of haematological toxicities following treatment of childhood hepatoblastoma with two different regimens of multi-agent chemotherapy. Methodology: This was a comparative observational study conducted at Bangabandhu Sheikh Mujib Medical university in 24 childhood hepatoblastoma patients who received either cisplatin/carboplatin /doxorubicin (Group A; n=14) or cisplatin/ vincristine/5- fluorouracil (Group B; n= 10) to between March 2010 and July 2014.
Results
Grade 3 or 4 anaemia and thrombocytopenia, and Grade 4 neutropenia were observed in 64.3% vs 60%, 35.7% vs 20% and 57.1% vs 20% respectively in group A and Group B. Febrile neutropenia occurred in 100% vs 70% and septicaemia developed in 92.9% vs 70%. Red cell concentrates and Platelet transfusions were required in 35.7% vs 50% and 14.3% vs 10% respectively in two groups. Deaths due to haematological toxicities occurred in 21.4% in Group A and 21% in Group B.
Conclusion
We found similar toxicity profiles for two chemotherapy regimens except for higher rates of febrile neutropenia and septicaemia in patients treated with cisplatin/carboplatin /doxorubicin compared to cisplatin/ vincristine/5- fluorouracil.
Zitieren
APA
Yasmin, F., Jamal, C. Y., Islam, A., Karim, M. A., & Begum, M. (2020). Haematological Toxicities Following Treatment of Childhood Hepatoblastoma with Intensive Multiagent Chemotherapy. Haematology Journal of Bangladesh. https://doi.org/10.37545/haematoljbd20172
Vancouver
Yasmin F, Jamal CY, Islam A, Karim MA, Begum M. Haematological Toxicities Following Treatment of Childhood Hepatoblastoma with Intensive Multiagent Chemotherapy. Haematology Journal of Bangladesh. 2020. doi:10.37545/haematoljbd20172
BibTeX
@article{Yasmin2020,
author = {Yasmin, Farida and Jamal, Chowdhury Yakub and Islam, Afiqul and Karim, Md. Anwarul and Begum, Mamtaz},
title = {Haematological Toxicities Following Treatment of Childhood Hepatoblastoma with Intensive Multiagent Chemotherapy},
journal = {Haematology Journal of Bangladesh},
year = {2020},
doi = {10.37545/haematoljbd20172}
}
EUVIMED